Rosos, Joshua G.
HRN: 08-09-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/26/2023
06/02/2023
IV DRIP
500mg
Q8
T/C Appendicitis
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes